Literature DB >> 28871640

A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence.

M Starr1, S M Sawyer1, J B Carlin1, Cve Powell1, R G Newman1, Pdr Johnson1.   

Abstract

OBJECTIVES: To evaluate the usefulness of a microelectronic tablet-dispenser for monitoring adherence to preventive therapy for tuberculosis infection in adolescents.
METHODOLOGY: Twenty-one patients with positive Mantoux tests were treated with isoniazid (INH), dispensed in a microelectronic tablet-dispenser that recorded the date, time and duration that the container was opened. Other measures of adherence included attendance at clinic, patient self-report, tablet count, and measurement of urinary INH metabolites.
RESULTS: The mean adherence rates were: 83% using attendance at clinic, 91% using tablet counts, 79% using urine assays, and 66% using the electronic tablet-dispenser. Self-reporting appeared to over-estimate adherence.
CONCLUSIONS: Adherence to 6 months of INH calculated using different measures is higher in this study than in previous reports. Microelectronic tablet-dispensers are an effective method to objectively measure adherence on a daily basis. Other measures are less helpful.

Entities:  

Keywords:  adherence; child; drug monitoring; isoniazid; tuberculosis

Year:  1999        PMID: 28871640     DOI: 10.1046/j.1440-1754.1999.00371.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

Review 1.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

2.  Lessons learned from two interventions designed to increase adherence to LTBI treatment in Latino youth.

Authors:  Melbourne F Hovell; Katharine E Schmitz; Elaine J Blumberg; Linda Hill; Carol Sipan; Lawrence Friedman
Journal:  Contemp Clin Trials Commun       Date:  2018-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.